FDA staff report backs GSK leukemia drug

09/14/2005 | Bloomberg

An FDA staff report says GlaxoSmithKline's Arranon appears to be effective against two rare types of blood cancer in cases where chemotherapy has not helped patients. An FDA advisory panel is scheduled to meet today to consider recommending approval of the drug.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA